{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:41:37Z","timestamp":1782884497623,"version":"3.54.5"},"reference-count":45,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brigitte und Dr. Konstanze Wegener-Stiftung","award":["A2024 I (12)"],"award-info":[{"award-number":["A2024 I (12)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is increasingly recognized as a systemic malignancy, characterized by profound alterations in tumor\u2013host interactions. Small extracellular vesicles (sEVs) in peripheral blood may reflect these alterations and represent a promising minimally invasive source of biomarker information. In this proof-of-principle study, plasma-derived sEVs from patients with PDAC, healthy controls, and a comparative cohort with neuroendocrine lung cancer (NLC) were isolated by differential ultracentrifugation and characterized by western blotting and nanoparticle tracking analysis. Surface marker profiling was performed using the MACSPlex EV Kit IO, followed by univariate, multivariate, and machine-learning-based analyses. PDAC samples exhibited a distinct sEV immunophenotype with coordinated enrichment of angiogenesis-related markers (including CD105 and CD146), immune-regulatory markers (including CD25 and CD40), the coagulation-related marker CD142 and the invasion-associated marker MCSP. Principal component analysis, hierarchical clustering, and Random Forest classification showed exploratory separation of PDAC patients from healthy controls and NLC, supporting the presence of disease-specific vesicle surface marker patterns. In a very small subset of paired samples, descriptive longitudinal analyses illustrated measurable intra-individual changes during chemotherapy. Plasma sEV immunophenotyping is a technically feasible approach for capturing systemic disease-associated alterations in PDAC and provides a foundation for future biomarker-oriented validation studies.<\/jats:p>","DOI":"10.3390\/biom16070942","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:06:34Z","timestamp":1782875194000},"page":"942","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Dimensional Immunophenotyping of Plasma-Derived Small Extracellular Vesicles in Pancreatic Cancer: An Exploratory Proof-of-Principle Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Sabrina","family":"Sulzer","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Lisa","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Domogalla","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Ellenrieder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7585-8956","authenticated-orcid":false,"given":"Markus","family":"Maulhardt","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Casimir","family":"Angleitner","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-7910","authenticated-orcid":false,"given":"Judith","family":"B\u00fcntzel","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/cam4.767","article-title":"Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030","volume":"5","author":"Quante","year":"2016","journal-title":"Cancer Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Michalak, N., and Ma\u0142ecka-Wojciesko, E. (2023). Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134318"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/SLA.0000000000004147","article-title":"Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?","volume":"275","author":"Strobel","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.gassur.2006.08.018","article-title":"1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience","volume":"10","author":"Winter","year":"2006","journal-title":"J. Gastrointest. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1055\/a-2338-3716","article-title":"S3-Leitlinie Exokrines Pankreaskarzinom\u2014Version 3.1","volume":"62","author":"Seufferlein","year":"2024","journal-title":"Z. Gastroenterol."},{"key":"ref_8","first-page":"900","article-title":"Lewis antigen-negative pancreatic cancer: An aggressive subgroup","volume":"56","author":"Liu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Goo, J., Lee, Y., Lee, J., Kim, I.S., and Jeong, C. (2024). Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16030311"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jhbp.601","article-title":"Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients","volume":"26","author":"Kawamura","year":"2019","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-020-01245-y","article-title":"The involvement of exosomes in the diagnosis and treatment of pancreatic cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Aiello","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103591","DOI":"10.4251\/wjgo.v17.i4.103591","article-title":"Exosomal biomarkers: A novel frontier in the diagnosis of gastrointestinal cancers","volume":"17","author":"Zhang","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1111\/cas.15500","article-title":"Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer","volume":"113","author":"Yoshioka","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ideno, N., Mori, Y., Nakamura, M., and Ohtsuka, T. (2020). Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121056"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1245\/s10434-019-07269-z","article-title":"Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma","volume":"26","author":"Nakamura","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2018.03.107","article-title":"Detection and proteomic characterization of extracellular vesicles in human pancreatic juice","volume":"499","author":"Osteikoetxea","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-Then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"ref_19","first-page":"55057","article-title":"Isolation and Characterization of Microvesicles from Peripheral Blood","volume":"119","author":"Menck","year":"2017","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00423-006-0140-7","article-title":"Systemic immune dysfunction in pancreatic cancer patients","volume":"392","author":"Poch","year":"2007","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3332\/ecancer.2022.1367","article-title":"Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status","volume":"16","author":"Ramaswamy","year":"2022","journal-title":"Ecancermedicalscience"},{"key":"ref_23","first-page":"58","article-title":"Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers","volume":"12","author":"Ramaswamy","year":"2023","journal-title":"F1000Research"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.21037\/jtd.2017.08.113","article-title":"Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer","volume":"9","author":"Franco","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00428-013-1463-8","article-title":"CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34","volume":"463","author":"Miyata","year":"2013","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1182\/blood-2009-06-229591","article-title":"Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia","volume":"115","author":"Harhouri","year":"2010","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ollauri-Ib\u00e1\u00f1ez, C., Ayuso-\u00cd\u00f1igo, B., and Pericacho, M. (2021). Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?. Cancers, 13.","DOI":"10.3390\/cancers13071552"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/cmi.2009.103","article-title":"CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4+ regulatory T cells","volume":"7","author":"Zheng","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MBC.0b013e3282ef99f6","article-title":"Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis","volume":"18","author":"Panasiuk","year":"2007","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhou, W., Huang, X., Jia, G., Lu, C., and Ma, W. (2026). CD24 as an innate immune checkpoint in solid tumors: Biology, biomarker stratification, and therapeutic translation. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1798585"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s43018-025-00963-w","article-title":"MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization","volume":"6","author":"Guetter","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/1078-0432.CCR-06-1893","article-title":"Prospect of targeting the CD40 pathway for cancer therapy","volume":"13","author":"Vonderheide","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_36","first-page":"1","article-title":"The role of endoglin in post-ischemic revascularization","volume":"20","author":"Pericacho","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.jproteome.7b00024","article-title":"Quantitative Proteomic Analysis of Serum Exo-somes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy","volume":"16","author":"An","year":"2017","journal-title":"J. Proteome Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"dju011","DOI":"10.1093\/jnci\/dju011","article-title":"Pancreatic Adenocarcinoma: Treating a Systemic Disease with Systemic Therapy","volume":"106","author":"Sohal","year":"2014","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.tranon.2019.07.009","article-title":"CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma","volume":"12","author":"Buscail","year":"2019","journal-title":"Transl. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","article-title":"Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer","volume":"289","author":"Kahlert","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Shafiekhani, S., Dehghanbanadaki, H., Fatemi, A.S., Rahbar, S., Hadjati, J., and Jafari, A.H. (2021). Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08770-z"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1078-0432.CCR-14-0365","article-title":"Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: Implications for early disease detection","volume":"21","author":"Sandanayake","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s12032-012-0278-9","article-title":"Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer","volume":"29","author":"Martin","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","article-title":"Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter","volume":"1875","author":"Luo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"David, P., Kouhestani, D., Hansen, F.J., Paul, S., Czubayko, F., Karabiber, A., Weisel, N., Kl\u00f6sch, B., Merkel, S., and Ole-Baur, J. (2025). Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041500"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/942\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:27:21Z","timestamp":1782880041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biom16070942"],"URL":"https:\/\/doi.org\/10.3390\/biom16070942","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}